Resumen
Background: The transmission of cytomegalovirus (TT-CMV) is a latent risk in blood transfusions despite preventive measures such as the use of leucoridated hemocomponents, however, CMV transmission is not completely excluded. Aim: To determine the seroprevalence of IgG-CMV and the relationship between seropositivity and the presence of CMV-DNA as a synonym for active infection. Methods: A transver-sal seroepidemiological study was carried out on 2953 donor samples by measuring the anti-IgG-CMV (ELISA DiaMEDIC), the results were classified into positive, indeterminate and negative, then the n of each group was calculated and the real-time pPCR (ROCHE) test was performed on a total of 466 samples according to the manufacturer’s specifications. Results: A seroprevalence of anti-IgG-CMV determined at 97,7% and 1,7% (n: 8) of samples were positive for DNA-CMV of which six serologically classified as positive and two unspecified. Discussion: There is a high seroprevalence of CMV in asymptomatic blood donors, but without correlation between the serological and molecular results, this is probably due to the latent state of the virus and a low amount of plasma DNA; however, there were 8 donors who were positive for DNA-CMV with the probability of being an active infection or reinfection.
| Título traducido de la contribución | Detection of cytomegalovirus in asymptomatic blood donors |
|---|---|
| Idioma original | Español |
| Páginas (desde-hasta) | 21-26 |
| Número de páginas | 6 |
| Publicación | Revista Chilena de Infectologia |
| Volumen | 42 |
| N.º | 1 |
| DOI | |
| Estado | Publicada - 2025 |
Nota bibliográfica
Publisher Copyright:© 2025, Sociedad Chilena de Infectologia. All rights reserved.
Palabras clave
- CMV
- DNA-CMV
- IgG antibodies
- blood donors
- cytomegalovirus